Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture-multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies-that deliver cost-effective and rapid results to clinicians and researchers.
Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
For further information on Luminex Corporation and the latest advances in multiplexing using award-winning technology, please visit www.luminexcorp.com